About Us

The Center for Cancer and Metabolism (CCM)

CCM is funded through the National Institutes of Health/National Institute of General Medical Sciences Centers of Biomedical Research Excellence (COBRE) program. The CCM was established in 2017 with the receipt of an $11 million Phase I COBRE grant award. The CCM Phase II was renewed and started in January 2022 with additional award of $10 million.

CCM Supports Four Research Projects

Those projects are from junior faculty members at UK whose research is dedicated to defining the role of metabolism in the development and treatment of cancer. Because these research projects are led by junior faculty / early-stage investigators, the CCM is heavily focused on developing their independent research careers and jump-starting their research into this exciting new area of cancer research. Support from the CCM, which provides them with rich mentoring experiences from both basic and clinical researchers, enhances their success in competing for eventual independent, extramural grant support.

Using CCM Services

It is imperative that all users of CCM facilities, services, and/or equipment cite the COBRE NIH grant in their publications and other materials. The following language is an example of how to cite CCM facilities funded through the COBRE program in your acknowledgements:

Research reported in this publication was supported by the University of Kentucky Center for Cancer and Metabolism, funded through the NIH/NIGMS COBRE program under grant number P20 GM121327.